Skip to content

CIK 0000806517

PMD PSYCHEMEDICS CORP

Insider trading from SEC Form 4. Last filing Dec 17, 2024.

PSYCHEMEDICS CORP (PMD) has 4 SEC Form 4 filings on file from 2 insiders, the latest filed on Dec 17, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

4 open-market trades have been scored at PMD. The newest: Powell Anderson Capital Partners LLC (10% owner) bought $305k of stock on Dec 13, 2024, filed Dec 17, 2024, scored 40 (moderate). The largest of the 4 shown: Peter Kamin (director and 10% owner) bought $3.3M on Dec 3, 2024, scored 58 (moderate). 2 insiders bought within 14 days of each other around Dec 13, 2024.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
2
with a Form 4 at this company

Signals

Open-market buys and sells at PSYCHEMEDICS CORP, scored.

ScoreInsiderValueHoldingsPrice contextFiled
40ModeratePowell Anderson Capital Partners LLC
owner
buy
$305k
159,700 shares
+32%-
42ModeratePeter Kamin
director, owner
sell
$754k
320,708 shares
-18%-
34WeakPowell Anderson Capital Partners LLC
owner
buy
$232k
86,991 shares
+21%-
58ModeratePeter Kamin
director, owner
buy
$3.3M
1,409,712 shares
+343%-

Transactions

Every row filed, 10 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Dec 13, 2024Powell Anderson Capital Partners LLC
owner
POpen-market purchase
Common Stockindirect: See footnote
+80,000$1.88$150k574,556Dec 17, 2024
Dec 16, 2024Powell Anderson Capital Partners LLC
owner
POpen-market purchase
Common Stockindirect: See footnote
+30,000$1.97$59k360,000Dec 17, 2024
Dec 16, 2024Powell Anderson Capital Partners LLC
owner
POpen-market purchase
Common Stockindirect: See footnote
+30,000$1.97$59k604,556Dec 17, 2024
Dec 17, 2024Powell Anderson Capital Partners LLC
owner
POpen-market purchase
Common Stockindirect: See footnote
+9,850$1.87$18k369,850Dec 17, 2024
Dec 17, 2024Powell Anderson Capital Partners LLC
owner
POpen-market purchase
Common Stockindirect: See footnote
+9,850$1.87$18k614,406Dec 17, 2024
Dec 10, 2024Peter Kamin
director, owner
SOpen-market sale
Common Stock, $0.005 Par Valueindirect: See footnote
-320,708$2.35$754k1,499,710Dec 12, 2024
Dec 10, 2024Powell Anderson Capital Partners LLC
owner
POpen-market purchase
Common Stockindirect: See footnote
+7,473$2.59$19k415,038Dec 12, 2024
Dec 11, 2024Powell Anderson Capital Partners LLC
owner
POpen-market purchase
Common Stockindirect: See footnote
+4,518$2.71$12k419,556Dec 12, 2024
Dec 12, 2024Powell Anderson Capital Partners LLC
owner
POpen-market purchase
Common Stockindirect: See footnote
+75,000$2.67$200k494,556Dec 12, 2024
Dec 3, 2024Peter Kamin
director, owner
POpen-market purchase
Common Stock, $0.005 Par Valueindirect: See footnote
+1,409,712$2.35$3.3M1,820,418Dec 5, 2024

Insiders

Everyone who has filed a Form 4 here.

Questions about PMD

Answered from the filings on this page, as of the latest one.

Are insiders buying PMD?

No. In the last 90 days no insider at PSYCHEMEDICS CORP bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade PMD on the open market?

Powell Anderson Capital Partners LLC (10% owner) bought $305k of PMD on Dec 13, 2024 and filed the Form 4 on Dec 17, 2024. InsiderTell scored 40 (moderate), with 2 insiders on the same side within 14 days.

How many insiders file Form 4 at PSYCHEMEDICS CORP?

2 people have filed a Form 4 at PSYCHEMEDICS CORP, among them Peter Kamin (director and 10% owner), Powell Anderson Capital Partners LLC (10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.